EXEL· Biotech / Healthcare

Exelixis, Inc.

PER 17.1ROE 41.0%

Fundamentals

P/E Ratio17.13
P/B Ratio6.78
ROE41.0%
Operating Margin41.1%
Revenue Growth10.0%
EPS3.02
Dividend Yield—
Debt Ratio8.8%
Free Cash Flow$629.12M
Market Cap$13.01B

Source: Yahoo Finance · Synced daily · Dividend yield expressed as decimal percent.

Sector Position

neutral
Biotech / HealthcareScore 584 stocks in universe

Peers in sector

CIThe Cigna Group
PER 2.6ROE 16.3%
INCYIncyte Corporation
PER 14.5ROE 30.8%
069620.KSDaewoong Pharmaceutical Co., Ltd
PER 6.5ROE 19.1%
AMGNAmgen Inc.
PER 24.3ROE 101.3%
DXCMDexCom, Inc.
PER 31.3ROE 35.6%

AI Insight

Exelixis, Inc. shows strong ROE 41.0%, PER 17.1, high operating margin 41.1%, revenue growth 10.0% based on the latest fundamentals snapshot.